Skip to main content
INBIOGEN CO.,Ltd logo

INBIOGEN CO.,Ltd — Investor Relations & Filings

Ticker · 101140 ISIN · KR7101140002 KO Professional, scientific and technical activities
Open in API
Filings indexed 341 across all filing types
Latest filing 2024-05-16 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 101140

About INBIOGEN CO.,Ltd

https://www.inbiogen.com/

INBIOGEN is a life sciences company that provides Virtual Biotech Assistance to international biotechnology companies, pharmaceutical firms, and research organizations. The company specializes in harnessing data mining to deliver a range of services, including bioinformatics, custom data curation, database development, and the creation of operational platforms. Core bioinformatics offerings encompass data analysis, protein modeling, homology searches, phylogeny, and immunogenicity analysis. Additionally, INBIOGEN provides virtual research, marketing assistance, and web development services. The company focuses on creating customized, value-added solutions through a team of experienced scientists and bioinformatics professionals to help clients address challenges and utilize online resources effectively.

Recent filings

Filing Released Lang Actions
분기보고서 (2024.03)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for the company 'Inbiogen' (주식회사 인바이오젠) covering the period from 2024.01.01 to 2024.03.31. It contains detailed sections including company overview, business operations, financial statements, and management analysis, which are characteristic of an interim/quarterly financial report. It is not an announcement of a report, but the report itself. Q1 2024
2024-05-16 Korean
기타시장안내 (개선기간 부여)
Legal Proceedings Report Classification · 100% confidence The document is an official notice from the Korea Exchange (KRX) regarding the status of Inbiogen, specifically announcing the granting of an improvement period due to delisting concerns following a disclaimer of opinion in the audit report. This is a regulatory announcement regarding market status and listing procedures, which falls under the 'Regulatory Filings' (RNS) category as it does not fit into specific categories like delisting (it is an extension/improvement period, not a final delisting) or legal proceedings.
2024-05-13 Korean
기타시장안내 (개선계획 이행여부에 대한 심의요청서 접수)
Legal Proceedings Report Classification · 100% confidence The document is an official notice from the Korea Exchange (KRX) regarding the status of Inbiogen's listing, specifically concerning the submission of a request for review of their improvement plan following a disclaimer of opinion by auditors. This is a regulatory announcement regarding market status and listing procedures, which falls under the 'Regulatory Filings' category as it does not fit into specific categories like M&A, dividends, or financial reports.
2024-04-25 Korean
기타시장안내 (개선기간 종료)
Delisting Announcement Classification · 100% confidence The document is an official notice from the Korea Exchange (KRX) regarding the status of Inbiogen's listing, specifically concerning the expiration of an improvement period and the subsequent delisting review process. It does not fit into specific categories like 'Delisting Announcement' (which usually refers to the final decision or company-initiated delisting) or 'Legal Proceedings'. As it is a general regulatory announcement regarding market status and listing procedures, it falls under the 'Regulatory Filings' (RNS) category as the appropriate fallback.
2024-04-16 Korean
기타시장안내 (상장폐지 이의신청서 제출)
Delisting Announcement Classification · 100% confidence The document is an official notice from the Korea Exchange (KRX) regarding the status of a company's listing. It specifically details the submission of an objection letter concerning potential delisting due to a disclaimer of opinion in the audit report. Since this document is a regulatory announcement regarding the listing status and potential delisting process rather than a final delisting notice or a financial report, it falls under the 'Regulatory Filings' category as a general market announcement.
2024-04-12 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official announcement of the results of a General Meeting of Shareholders (AGM), detailing the approval of financial statements, board appointments, and other resolutions. It explicitly uses the header '정기주주총회결과' (Regular General Meeting Results). This falls under the category of Declaration of Voting Results & Voting Rights Announcements.
2024-03-29 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.